UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056958 |
|---|---|
| Receipt number | R000065092 |
| Scientific Title | Transcatheter arterial embolization for blunt splenic injury and pseudoaneurysm, and study of additional embolization |
| Date of disclosure of the study information | 2025/02/06 |
| Last modified on | 2025/02/06 17:27:49 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Transcatheter arterial embolization for blunt splenic injury and pseudoaneurysm, and study of additional embolization
Acronym
Research on blunt splenic injuries
Scientific Title
Transcatheter arterial embolization for blunt splenic injury and pseudoaneurysm, and study of additional embolization
Scientific Title:Acronym
Research on blunt splenic injuries
Region
| Japan |
Condition
Condition
Blunt splenic injury
Classification by specialty
| Emergency medicine | Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the occurrence of pseudoaneurysms after conservative treatment of blunt splenic injuries, including whether transcatheter arterial embolization is performed, to identify the need for follow-up and the need for additional embolization or other treatment of pseudoaneurysms
Basic objectives2
Others
Basic objectives -Others
N/A
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Development of pseudoaneurysm
Key secondary outcomes
Additional embolization
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 99 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Patients diagnosed with splenic injury between January 1, 2018 and December 31, 2023
Key exclusion criteria
(1) Patients with cardiopulmonary arrest at the time of admission
(2) Patients who have not undergone contrast-enhanced CT
(3) Patients who have opted out of the use of information.
Target sample size
66
Research contact person
Name of lead principal investigator
| 1st name | Fuminori |
| Middle name | |
| Last name | Yamaji |
Organization
Gifu University Hospital
Division name
Advanced Critical Care Center
Zip code
501-1194
Address
1-1 Yanagido, Gifu
TEL
0582306448
g.yama.fumi@gmail.com
Public contact
Name of contact person
| 1st name | Fuminori |
| Middle name | |
| Last name | Yamaji |
Organization
Gifu University Hospital
Division name
Advanced Critical Care Center
Zip code
501-1194
Address
1-1 Yanagido, Gifu
TEL
0582306448
Homepage URL
g.yama.fumi@gmail.com
Sponsor or person
Institute
Gifu University
Institute
Department
Personal name
Funding Source
Organization
Gifu University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Medical Ethics Committee of the Gifu University Graduate School of Medicine, Gifu, Japan
Address
1-1 Yanagido, Gifu
Tel
0582306448
rinri@t.gifu-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 02 | Month | 06 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
66
Results
The causes of injury included traffic accidents (28 patients), falls from heights (20 patients), snowboarding-related trauma (10 patients), and other causes (eight patients). According to the 2018 revised American Association for the Surgery of Trauma-Organ Injury Scale, there were 14, 10, 16, 17, and 9 grade I, II, III, IV, and V injuries, respectively. T
Results date posted
| 2025 | Year | 02 | Month | 06 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2024 | Year | 05 | Month | 12 | Day |
Date of IRB
| 2024 | Year | 07 | Month | 08 | Day |
Anticipated trial start date
| 2024 | Year | 07 | Month | 08 | Day |
Last follow-up date
| 2024 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We will retrospectively study 66 patients with blunt splenic injuries who were brought to our hospital as emergencies during a 6-year period from January 1, 2018 to December 31, 2023, using electronic medical records. We will investigate the treatment of splenic injuries (TAE, conservative treatment), the occurrence of pseudoaneurysms on subsequent follow-up contrast-enhanced CT scans, and additional embolization procedures for them. To investigate the incidence of pseudoaneurysms and the need for follow-up and additional embolization.
Management information
Registered date
| 2025 | Year | 02 | Month | 06 | Day |
Last modified on
| 2025 | Year | 02 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065092
